405 related articles for article (PubMed ID: 14662025)
1. Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2).
Sato M; Takayama T; Tanaka H; Konishi J; Suzuki T; Kaiga T; Tahara H
Cancer Sci; 2003 Dec; 94(12):1091-8. PubMed ID: 14662025
[TBL] [Abstract][Full Text] [Related]
2. The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?
Lee JJ; Takei M; Hori S; Inoue Y; Harada Y; Tanosaki R; Kanda Y; Kami M; Makimoto A; Mineishi S; Kawai H; Shimosaka A; Heike Y; Ikarashi Y; Wakasugi H; Takaue Y; Hwang TJ; Kim HJ; Kakizoe T
Stem Cells; 2002; 20(5):448-59. PubMed ID: 12351815
[TBL] [Abstract][Full Text] [Related]
3. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
Pan K; Lv L; Zheng HX; Zhao JJ; Pan QZ; Li JJ; Weng DS; Wang DD; Jiang SS; Chang AE; Li Q; Xia JC
Immunol Cell Biol; 2014 Mar; 92(3):263-74. PubMed ID: 24296809
[TBL] [Abstract][Full Text] [Related]
4. Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers.
Sakakibara M; Kanto T; Inoue M; Kaimori A; Yakushijin T; Miyatake H; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Immunother; 2006; 29(1):67-77. PubMed ID: 16365602
[TBL] [Abstract][Full Text] [Related]
5. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
[TBL] [Abstract][Full Text] [Related]
6. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets.
Luft T; Jefford M; Luetjens P; Toy T; Hochrein H; Masterman KA; Maliszewski C; Shortman K; Cebon J; Maraskovsky E
Blood; 2002 Aug; 100(4):1362-72. PubMed ID: 12149219
[TBL] [Abstract][Full Text] [Related]
7. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
8. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
9. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
[TBL] [Abstract][Full Text] [Related]
10. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
[TBL] [Abstract][Full Text] [Related]
11. Effective strategy of dendritic cell-based immunotherapy for advanced tumor-bearing hosts: the critical role of Th1-dominant immunity.
Mashino K; Sadanaga N; Tanaka F; Ohta M; Yamaguchi H; Mori M
Mol Cancer Ther; 2002 Aug; 1(10):785-94. PubMed ID: 12492111
[TBL] [Abstract][Full Text] [Related]
12. Streptococcal preparation OK432 promotes functional maturation of human monocyte-derived dendritic cells.
Itoh T; Ueda Y; Okugawa K; Fujiwara H; Fuji N; Yamashita T; Fujiki H; Harada S; Yoshimura T; Yamagishi H
Cancer Immunol Immunother; 2003 Apr; 52(4):207-14. PubMed ID: 12669245
[TBL] [Abstract][Full Text] [Related]
13. 3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E
Yi DH; Stetter N; Jakobsen K; Jonsson R; Appel S
Cancer Immunol Immunother; 2018 Oct; 67(10):1611-1620. PubMed ID: 30069688
[TBL] [Abstract][Full Text] [Related]
14. Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells.
Schreibelt G; Benitez-Ribas D; Schuurhuis D; Lambeck AJ; van Hout-Kuijer M; Schaft N; Punt CJ; Figdor CG; Adema GJ; de Vries IJ
Blood; 2010 Jul; 116(4):564-74. PubMed ID: 20424184
[TBL] [Abstract][Full Text] [Related]
15. Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells.
Yang M; Ma C; Sun J; Shao Q; Gao W; Zhang Y; Li Z; Xie Q; Dong Z; Qu X
Int Immunopharmacol; 2008 Dec; 8(13-14):1754-60. PubMed ID: 18783737
[TBL] [Abstract][Full Text] [Related]
16. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.
Dauer M; Pohl K; Obermaier B; Meskendahl T; Röbe J; Schnurr M; Endres S; Eigler A
Immunology; 2003 Sep; 110(1):38-47. PubMed ID: 12941139
[TBL] [Abstract][Full Text] [Related]
18. A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy.
Lee AW; Truong T; Bickham K; Fonteneau JF; Larsson M; Da Silva I; Somersan S; Thomas EK; Bhardwaj N
Vaccine; 2002 Dec; 20 Suppl 4():A8-A22. PubMed ID: 12477423
[TBL] [Abstract][Full Text] [Related]
19. Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity.
Koya T; Yanagisawa R; Higuchi Y; Sano K; Shimodaira S
Sci Rep; 2017 Feb; 7():42145. PubMed ID: 28191816
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy.
Hansen M; Hjortø GM; Donia M; Met Ö; Larsen NB; Andersen MH; thor Straten P; Svane IM
Vaccine; 2013 Jan; 31(4):639-46. PubMed ID: 23200882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
